Navigation Links
Cancer gene mystery to be cracked!

A major research project is to be launched by researchers from the UK and Netherlands in the hope of identifying the cluster of genes associated with cancer. The research will be led by Dr. Julian Downward from Cancer Research UK’s London Research Institute, along with Dr. René Bernards of the Netherlands Cancer Institute. This research will build on the success of the human genome project and will have scientists looking at nearly 10,000 genes, inactivating one at a time to find out precisely what they do and how they contribute to the development of cancer. They hope// that this effort will ultimately lead to the creation of new drugs that target rogue cancer-causing genes.

Scientists will use a process called RNA interference to switch off certain genes and leave others unaffected. This process was first identified as taking place in the nematode worm. It was discovered that the worm used tiny pieces of double-stranded RNA to switch off rogue genes that would otherwise harm it. Subsequently, researchers found that synthetically produced RNA sequences could be used to target genes in human cells. Using this discovery, scientists will bombard cancer cells with 30,000 pieces of interference RNA in an effort to discover the genetic essence of a malignant cell. The researchers will then screen the treated cells for those that have reverted to type and become normal again. They hope that those genes switched off by RNA interference in these cells may represent a crucial group of genes, which future anti-cancer drugs could target.

Dr. Downward concluded that they were confident that they would precisely find out what needs to be taken away from cancerous cells to make it normal again. Sir Paul Nurse, Chief Executive of Cancer Research, UK, on the other hand, added that the next challenge for scientists was to unravel the mystery of each human gene and find out what each gene was doing. This would help in working out which of them are playing import ant roles in cancer and other diseases.

'"/>




Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2016)... ... 2016 , ... In the fourth quarter of 2015, document ... La Valencia Hotel in San Diego, California to discuss changes in the industry ... outstanding franchise, walking away with the coveted David Wright Award of Excellence. ...
(Date:2/5/2016)... ... 2016 , ... Pivot Point Consulting, a leading national Healthcare ... Services for HIT Implementation Support & Staffing report with an outstanding score of ... healthcare executives, managers and clinicians representing over 4,500 hospitals and 2,500 clinics. , ...
(Date:2/5/2016)... ... 05, 2016 , ... Colorize is a web theme package created ... next using Colorize's dynamic moving camera. Colorize is perfect for personal and web related ... environment with 1 to 5 focus points per scene, stage floor scene presets that ...
(Date:2/5/2016)... , ... February 05, 2016 , ... Calls Blacklist has ... completely new user interface design and the developer has fixed known bugs within the ... want to on their phone while not consuming any of their device’s battery power ...
(Date:2/4/2016)... Palos Verdes, CA (PRWEB) , ... February 04, ... ... present at the "It's All About YOU Re-Treat" on February 19-21, 2016, ... You Re-Treat" is at Rancho Palos Verdes, California. These 30 professional speakers, including ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... 2016 Wegener Polyangiitis - Pipeline Review, ... ,Wegener Polyangiitis - Pipeline Review, H2 2015, provides ... This report provides comprehensive information on the ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ...
(Date:2/4/2016)... 4, 2016 Frontier Pharma: Chronic Obstructive ... Innovation Chronic Obstructive Pulmonary Disease ... inflammation of the airways and lungs. Persistent breathing ... the disease one of the leading causes of ... the world. COPD is linked to cumulative exposure ...
(Date:2/4/2016)... Feb. 4, 2016 In response to the opioid ... Deputy Commissioner for Medical Products and Tobacco, along with other ... the agency,s approach to opioid medications. The plan will focus ... patients in pain access to effective relief. ... , Re-examine the risk-benefit paradigm for opioids and ensure ...
Breaking Medicine Technology: